Consequently, targeting MMP-2 and MMP-9 may offer therapeutic potential for inhibiting EMT and metastasis in melanoma The MMP-9’s enzymatic breakdown of ECM barriers modulates the tumor microenvironment to facilitate metastasis (29). The gene discussed is MMP2; the disease is melanoma.